Compare NeoGenomics Inc. Common Stock (NEO) vs Nutrien Ltd (NTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Nutrien Ltd — how do they compare? NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B), while Nutrien Ltd trades at $70.38 (market cap $33.39B). The key difference: Nutrien Ltd is far larger — about 15.4× NeoGenomics Inc. Common Stock's market cap, and Nutrien Ltd pays a 3.15% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Nutrien Ltd for 60 Days on average.
| NEO | NTR | |
|---|---|---|
Market Cap | $2.17B | $33.39B |
Volume | 1,615,943 | 2,147,139 |
Sector | Health | Basic Materials |
52-Week High | $19.91 | $83.94 |
52-Week Low | $7.19 | $53.64 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $2.47B | $45.20B |
Dividend Yield | — | 3.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nutrien (NTR) trades at $69.68, up 2.47% with mixed technical signals showing bearish momentum but oversold conditions on some indicators. The company reported $26.89B revenue for 2025 with net income of $2.27B, representing improved profitability from 2024. Recent news highlights fertilizer industry headwinds but also strong potash demand and upcoming investor day in November 2026.
The stock presents a moderate buy opportunity with analyst consensus target of $77.29 (11% upside) despite near-term volatility. Key risks include fertilizer price sensitivity, competitive pressures, and geopolitical factors affecting agricultural markets. The company's strong cash flow generation and institutional interest support long-term value proposition.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →
